[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Mesoblast Ltd ADR (MESO)

Mesoblast Ltd ADR (MESO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Mesoblast Ltd ADR LEVEL 38 55 COLLINS STREET MELBOURNE C3 3000 AUS

www.mesoblast.com Employees: 81 P: 61-3-9639-6036 F: +61 396396030

Sector:

Medical

Description:

Mesoblast Limited is a global leader in developing innovative cell-based medicines. The Company has leveraged its proprietary technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a broad portfolio of late-stage product candidates. Mesoblast's allogeneic, 'off-the-shelf' cell product candidates target advanced stages of diseases with high, unmet medical needs including cardiovascular conditions, orthopedic disorders, immunologic and inflammatory disorders and oncologic/hematologic conditions.

Key Statistics

Overview:

Market Capitalization, $K 1,932,853
Enterprise Value, $K 1,893,203
Shares Outstanding, K 129,461
Float, K 105,122
% Float 81.20%
Short Interest, K 2,942
Short Float 2.27%
Days to Cover 17.91
Short Volume Ratio 0.49
% of Insider Shareholders 18.80%
% of Institutional Shareholders 1.43%

Financials:

Annual Sales, $ 17,200 K
Annual Net Income, $ -102,140 K
Last Quarter Sales, $ 1,930 K
Last Quarter Net Income, $ -21,920 K
EBIT, $ -31,170 K
EBITDA, $ -24,770 K

Growth:

1-Year Return 20.16%
3-Year Return 110.88%
5-Year Return -12.49%
5-Year Revenue Growth -46.52%
5-Year Earnings Growth 42.57%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 02/26/26
Earnings Per Share ttm -0.54
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-2 on 01/10/24

MESO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -593.84%
Debt/Equity 0.22
Price/Sales 109.30
Price/Cash Flow N/A
Price/Book 3.26
Book Value/Share 4.45
Interest Coverage -3.43
60-Month Beta 2.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.